Introduction to Business Development Strategies for Entering the European Market
[Asia Economy Reporter Myunghwan Lee] The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on the 17th that it will hold the 'Europe Pharmaceutical and Bio Market Entry Forum I' online on the 22nd for domestic pharmaceutical and bio companies in collaboration with the Korea-Switzerland Bio-Pharma Network (KSBPN).
KSBPN was established in 2022 by about 40 Korean employees working in pharmaceutical and bio companies, universities, and life science research institutes in Switzerland.
Korea Pharmaceutical and Bio-Pharma Manufacturers Association building. [Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association]
In this webinar, overall strategies for entering the European market and trends in new drug development in Switzerland will be explained. Dr. Juha Kim, president of the Korea-Switzerland Bio-Pharma Network, will present on topics including ▲Introduction to the Korea-Switzerland Bio-Pharma Network (KSBPN) ▲Understanding the Swiss pharmaceutical and bio business ecosystem ▲Step-by-step entry strategies and considerations for selecting locations and bases.
Following this, Team Leader Guyoung Jung and Dr. Donghoon Kim from Ipsomed, a Swiss pharmaceutical company providing digital solutions, will discuss trends in developing digital solutions for effective drug delivery in Switzerland.
An association official stated, "This will be an opportunity to gain a comprehensive understanding of the European pharmaceutical and bio market and to address questions about Switzerland, which has an innovative ecosystem equipped with large-scale cutting-edge research facilities," adding, "We will continue to support networking with the pharmaceutical and bio industry and experts within Europe."
The association plans to hold follow-up seminars in the first half of the year to assist domestic pharmaceutical and bio companies in entering the European market.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
